Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:2128-2135.

Slides:

Advertisements

Similar presentations

Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.

Advertisements

The Impact of Cost-Sharing on Adherence to Antihypertensive Drugs for Low and High Adherers Jean Yoon UCLA Department of Health Services.

Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD*

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: /NEJMSA Niteesh K. Choudhry,

Deductible-based Health Insurance Plans: Are Complex Deductible Exemptions Confusing Patients? Mary Reed, DrPH Center for Health Policy Studies, Kaiser.

Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.

THOMSON SCIENTIFIC & HEALTHCARE ISPOR 11 th Annual International Meeting This study was funded by Pfizer, Inc. May 24, 2006 The Effects of Statin (HMG-CoA.

RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.

Incretin-Based Drugs and the Risk of Congestive Heart Failure Featured Article: Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Valerie Patenaude,

1 Value Based Designs Charles M. Cutler, MD, MS National Medical Director Aetna, Inc.

Clinical Trial Results. org Relationship Between Adherence to Evidence- Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction.

Utilization Of Lipid-lowering Therapy In Hypertensive Patients In The United States Simon S.K. Tang, MPH* Sean Candrilli, MS** Lizheng Shi, PhD* *Department.

Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.

Coinsurance. Cost Sharing Policies Service benefit policies use three cost- sharing features, sometimes in concert: the deductible, the coinsurance rate,

Employer-Sponsored Health Insurance for Early Retirees: Impacts on Retirement, Health and Health Care Erin Strumpf, Ph.D. McGill University AcademyHealth.

Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.

THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.

Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Sebastian Schneeweiss, M.D., Sc.D. Instructor in Medicine and Epidemiology Director for Policy Studies Division of Pharmacoepidemiology and Pharmacoeconomics.

F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.

Atypical Presentations Patients older than 75: frequently no chest pain ECG in evolution (nonspecific ECG changes) Diabetic patients: commonly no chest.

Cost-Sharing and Screening Mammography Amal Trivedi, MD, MPH 2008 AcademyHealth Annual Research Meeting.

2007May221 Journal Club for Analysis of Complex Datasets Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic,

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Prescription Drug Coverage Enrollment in Beneficiaries With Glaucoma Blumberg.

Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

Transparency in the Use of Propensity Score Methods

Hippisley-Cox J, Coupland C. Heart 2010;96:

STATINS ARE ASSOCIATED WITH A DECREASED RISK OF DECOMPENSATION AND DEATH IN VETERANS WITH HEPATITIS C-RELATED COMPENSATED CIRRHOSIS PREPARED BY PAULINA.

Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,

Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.

Accutane ® Use and Epidemiology John E. La Flore, MD, MSPH Vice President, Drug Safety & Risk Management Hoffmann-La Roche Inc.

Evaluation of health policy effects Source: Analysis of Health and Welfare Surveys (HWS, various years) 1. UC implemented Oct SS extended Apr 02.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Search strategy and results Amir Kashani, et al. Circulation. 2006;114:

Discontinuation of medication after nonfatal event: MI

Evaluating Policies in Cardiovascular Medicine

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:

by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E

by Alexander Kulik, Ian G. Burwash, Varun Kapila, Thierry G

Diabetes hazard rates by number of visits with reported statin use.

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II

Global Registry of Acute Coronary Events: GRACE

Patient characteristics in the entire study group

Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.

Nat. Rev. Cardiol. doi: /nrcardio

Pamela E. Scott et al. JACC 2018;71:

A.V. Khera et al. N Engl J Med 2011;364:127-35

Adjusted annual percentage of quality indicators by prescription

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Characteristics of Large Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. et al. JACC 2008 Aug 20 [Epub ahead of print]

Baseline Characteristics by hs-CRP

(A) Absolute and (B) change from baseline in 6 min walk distance over time for all patients and by Down syndrome status. (A) Absolute and (B) change from.

Flow chart of search strategy

The 6MWT results showing improvement from baseline at 1, 6 and 12 months in patients receiving an implant (mean±SE of mean). The 6MWT results showing improvement.

T2DM patients with HF may benefit from SGLT2 inhibitor therapy

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Risk of PTC associated with serum concentrations of TSH and thyroid hormones among females, stratified by tumor size. *, Conditional logistic regression,

Increase of physical activity over time associated with lower HF risk

A: Forest plot of the HR of AE of bone fracture between the saxagliptin and placebo groups across subgroups by demographic and medical history parameters.

Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.

One-year costs by evaluation strategy.

Fig 2 Predicted probabilities of being in each of the five change in substance use categories (change from baseline in average daily amount of main substance)

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:

Baseline Covariates for 3 Cohorts of New Statin Users Sebastian Schneeweiss, et al. Circulation 2007;115:

Adherence for the baseline, copayment, and coinsurance cohorts showing a sudden decline in adherence 100 days (equal to the median prescription supply) after the policy changes Sebastian Schneeweiss, et al. Circulation 2007;115:

New initiations of statin therapy after AMI at baseline and under a copayment and coinsurance policy Sebastian Schneeweiss, et al. Circulation 2007;115:

Independent Risk Factors for Discontinuing Statin Therapy, From Logistic Regression Analysis* S. Schneeweiss, et al. Circulation 2007;115: CHF indicates congestive heart failure. *Each factor was adjusted for all other factors and represents independent effect estimates. The effects of patient risk factors are therefore independent of the policy effects in this analysis. †The 100% coinsurance policy affected a fair proportion of elderly beneficiaries because the policy required deductible payments that were based on income. Before this deductible was reached, patients had to pay 100% of costs out of pocket.